Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Revenue (2016 - 2025)

Historic Revenue for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $9.8 million.

  • Utah Medical Products' Revenue fell 192.9% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 1235.54%. This contributed to the annual value of $40.9 million for FY2024, which is 1855.89% down from last year.
  • Utah Medical Products' Revenue amounted to $9.8 million in Q3 2025, which was down 192.9% from $10.0 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Revenue high stood at $13.6 million for Q4 2022, and its period low was $9.2 million during Q4 2024.
  • Its 5-year average for Revenue is $11.7 million, with a median of $12.3 million in 2023.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 4343.92% in 2021, then tumbled by 2575.2% in 2024.
  • Utah Medical Products' Revenue (Quarter) stood at $12.9 million in 2021, then increased by 5.12% to $13.6 million in 2022, then dropped by 9.15% to $12.3 million in 2023, then decreased by 25.75% to $9.2 million in 2024, then rose by 7.15% to $9.8 million in 2025.
  • Its Revenue was $9.8 million in Q3 2025, compared to $10.0 million in Q2 2025 and $9.7 million in Q1 2025.